Featured News
AIM Blog
Recognizing AIM’s August Advocate of the Month: Vinitia Strong-McDonald
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...
Press Release
Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means
— Congressional Bipartisan Support for Individuals, Families and Treatment on Display — WASHINGTON, D.C., May 10, 2023 — Today, Tony...
Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...
Press Release
Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing
Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...
Press Release
Alzheimer’s Advocates Turn House Budget Hearings Purple, Building Bipartisan Momentum for Access to FDA-Approved Alzheimer’s Treatments
Alzheimer’s Association and Advocates Urge HHS Secretary to Cover Alzheimer’s Treatments Washington, D.C., March 29, 2023 — Alzheimer’s Association advocates...